Albany Molecular Research Inc. on Tuesday reported it lost $5.9 million on revenues of $50.2 million in the third quarter ending Sept. 30, compared to a loss of $9.9 million on revenues of $50.6 million a year earlier. The company also announced it was ceasing internal R&D program activities, excluding its generic program, in a […]

Source: http://blog.timesunion.com/business/amri-revenues-flat-but-loss-narrows-in-third-quarter/52036/

re election ron paul voter confidence oval office

Advertisements